The genes that AAVs can carry for treating AD include those encoding soluble amyloid precursor protein α (sAPPα), neprilysin (NEP), endothelin‐converting enzyme 1 (ECE1), apolipoprotein E2 (ApoE2), and transcription factor EB (TFEB), among others. Here, TFEB is linked to Alzheimer disease.